• Users Online: 379
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Reader Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Most cited articles *

 
 
  Archives   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
REVIEW ARTICLES
Itraconazole: What clinicians should know?
Piet De Doncker, Sushil Pande, Ute Richarz, Nishant Garodia
January-June 2017, 3(1):4-10
DOI:10.4103/ijdd.ijdd_20_17  
  16 15,390 1,534
ORIGINAL ARTICLES
Tuberculin purified protein derivative immunotherapy in the treatment of viral warts
Ajay Nimbalkar, Sushil Pande, Ramesh Sharma, Milind Borkar
January-June 2016, 2(1):19-23
DOI:10.4103/2455-3972.184103  
  8 12,960 545
EDITORIAL
Clinical failure of antifungal therapy of dermatophytoses: Recurrence, resistance, and remedy
Ragunatha Shivanna, Arun C Inamadar
January-June 2017, 3(1):1-3
DOI:10.4103/ijdd.ijdd_13_17  
  7 9,707 984
ORIGINAL ARTICLES
Effect of measles mumps rubella vaccine in treatment of common warts
Anuja Dhope, Bhushan Madke, Adarsh Lata Singh
January-June 2017, 3(1):14-19
DOI:10.4103/ijdd.ijdd_1_17  
  5 12,965 480
REVIEW ARTICLE
Apremilast: A dermatologic perspective
Aditya Kumar Bubna
July-December 2016, 2(2):75-82
DOI:10.4103/2455-3972.196166  
  5 16,833 1,650
BRIEF REPORT
Successful use of oral acitretin in oral lichen planus
Ajay Deshpande
January-June 2017, 3(1):24-27
DOI:10.4103/ijdd.ijdd_9_17  
  4 6,510 198
EDITORIAL
Steroid containing fixed drug combinations banned by government of India: A big step towards dermatologic drug safety
Sushil Pande
January-June 2016, 2(1):1-2
DOI:10.4103/2455-3972.184102  
  4 9,353 343
CASE REPORTS
Generalized bullous fixed drug reaction: A close similarity to stevens–johnson syndrome
Bhagyashri Daulatabadkar, Sushil Pande, Milind Borkar
January-June 2017, 3(1):28-31
DOI:10.4103/ijdd.ijdd_11_17  
  3 8,047 293
EDITORIAL
Tranexamic acid in melasma: Why and how?
Shuken Dashore, Katyain Mishra
July-December 2017, 3(2):61-63
DOI:10.4103/ijdd.ijdd_37_17  
  3 56,133 1,186
LETTERS TO EDITOR
Azathioprine-induced alopecia as an early clinical marker of its myelotoxicity
Anil B Bhokare
January-June 2017, 3(1):40-41
DOI:10.4103/ijdd.ijdd_4_17  
  3 17,892 133
ORIGINAL ARTICLES
A clinical study of severe cutaneous adverse drug reactions and role of corticosteroids in their management
Rohini Sharma, Naina Dogra, Devraj Dogra
January-June 2017, 3(1):20-23
DOI:10.4103/ijdd.ijdd_22_16  
  3 2,596 205
A study of clinical patterns and causative agents of adverse cutaneous drug reactions
Nilesh Mahatme, R Narasimharao
January-June 2016, 2(1):13-18
DOI:10.4103/2455-3972.184088  
  3 2,920 263
REVIEW ARTICLE
Bilastine: A novel antihistamine
Jeet Gandhi, Kiran Godse, Gauri Godse
January-June 2018, 4(1):3-6
DOI:10.4103/ijdd.ijdd_12_18  
  3 21,940 1,391
ALTERNATIVE MEDICINE
Homeopathic management of warts
Piyush Mahendra Oza
January-June 2016, 2(1):45-47
DOI:10.4103/2455-3972.184085  
  2 153,984 775
EDITORIAL
Biologics in psoriasis: Indian experience
Shrichand G Parasramani, Jisha Pillai
January-June 2019, 5(1):1-5
DOI:10.4103/ijdd.ijdd_33_19  
  2 10,617 649
Omalizumab in the treatment of chronic urticaria
Kiran Godse
January-June 2018, 4(1):1-2
DOI:10.4103/ijdd.ijdd_19_18  
  2 6,319 310
ORIGINAL ARTICLES
Clinical spectrum of cutaneous adverse drug reactions
Ankita Agrawal, Smita Ghate, Abhishek Kumar Gupta, Rachita Dhurat
July-December 2018, 4(2):61-66
DOI:10.4103/ijdd.ijdd_14_18  
  2 3,252 269
VIVA VOCE
Rituximab in the treatment of skin diseases
Murlidhar Rajagopalan, Resham Vasani
July-December 2017, 3(2):105-109
DOI:10.4103/ijdd.ijdd_31_17  
  2 5,660 485
CASE REPORTS
Nicolau syndrome: A rarely seen iatrogenic fatal cutaneous reaction following intramuscular diclofenac injection
Anup Kumar Tiwary, Rohit K Aggarwal
July-December 2016, 2(2):99-101
DOI:10.4103/2455-3972.196171  
  1 2,693 117
EDITORIAL
Purified protein derivative immunotherapy for viral warts and interpretation of tuberculin skin tests and interferon gamma release assay for diagnosis of tuberculosis in India
Sushil Pande, Anil Sontakke, BO Tayade
July-December 2016, 2(2):73-74
DOI:10.4103/2455-3972.196165  
  1 2,512 143
LETTERS TO EDITOR
Urticarial rash after tranexamic acid infusion
Raghavendra Vagyannavar, Rekha Devi, Vandna Bharti
January-June 2017, 3(1):43-44
DOI:10.4103/ijdd.ijdd_5_17  
  1 1,585 57
Levetiracetam-induced maculopapular rash: A rare side effect
Mahesh M Unni, Dinesh Verma, Ruikar Devashish
July-December 2016, 2(2):109-111
DOI:10.4103/2455-3972.196204  
  1 5,460 103
ORIGINAL ARTICLES
Different treatment modalities in the treatment of childhood lichen planus
Urmila Nischal, Vidya Kharkar
July-December 2016, 2(2):87-92
DOI:10.4103/2455-3972.196168  
  1 6,570 283
TABLE
Maculopapular drug eruption versus maculopapular viral exanthem
Bhavana R Doshi, BS Manjunathswamy
January-June 2017, 3(1):45-47
DOI:10.4103/ijdd.ijdd_19_17  
  1 15,997 831
VIVA VOCE
Viva Voce on omalizumab
Kiran Godse, Resham Vasani
July-December 2016, 2(2):121-123
DOI:10.4103/2455-3972.196227  
  1 3,198 246
* Source: CrossRef